Lasers a transforma prostate treatment

The approach, tested across Europe, uses lasers and a drug made from deep sea bacteria to eliminate tumours, but without causing severe side effects. Trials on 413 men published in The Lancet Oncology showed nearly half of them had no remaining trace of cancer.

Prostate cancer laser therapy ‘huge leap forward’

A drug activated by laser light which successfully destroys early prostate cancer while avoiding surgery side effects has been labelled a “huge leap” forward. Trial results reflected favourably on the new technique, called vascular-targeted photodynamic therapy , in comparison to standard prostate cancer care.

Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424

Threshold Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for cancer, today announced that it has entered into a collaboration with the National Cancer Institute , part of the National Institutes of Health , to study TH-3424, the company’s new drug candidate for the treatment of cancer. The collaboration will explore the effects of TH-3424 against T-cell acute lymphoblastic leukemia xenograft cell lines with high AKR1C3 expression.